|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.42 USD | +0.06% |
|
+0.06% | +34.62% |
| 06-24 | Catalyst and Angelini Pharma Merger Receives Early Termination of Waiting Period Under HSR Act | MT |
| 05-22 | CVC, GBL launch EUR10.7 billion bid for Italian drugmaker Recordati | RE |
| Market Cap | 3.85B 3.39B 3.12B 2.92B 5.47B 362B 5.57B 37.53B 14.53B 179B 14.44B 14.12B 622B | P/E 2026 * |
16.1x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.85B 3.39B 3.12B 2.92B 5.47B 362B 5.57B 37.53B 14.53B 179B 14.44B 14.12B 622B | EV / Sales 2026 * |
6.04x | EV / Sales 2027 * | 5.36x |
| Free-Float |
94.43% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.06% | ||
| 1 week | +0.06% | ||
| Current month | +0.61% | ||
| 1 month | +0.51% | ||
| 3 months | +36.19% | ||
| 6 months | +28.51% | ||
| Current year | +34.62% |
| 1 week | 31.36 |  | 31.43 |
| 1 month | 31.23 | | 31.43 |
| Current year | 22.13 | | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.68 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 01/01/2024 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 01/01/2024 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick McEnany
CHM | Chairman | 78 | 01/01/2002 |
David Tierney
BRD | Director/Board Member | 62 | 01/10/2002 |
Richard Daly
BRD | Director/Board Member | 65 | 19/02/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-03 | Fiscal year | Chief Technology Officer | 3,795 | 0.0031% | ||
| 02-17 | Fiscal year | Head of Human Resources | 1,585 | 0.0013% | ||
| 01-05 | Fiscal year | Chief Executive Officer | 94,787 | 0.0771% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +0.06% | +42.37% | +138.94% | 3.85B | |
| +0.87% | +2.55% | +19.37% | -20.05% | 63.43B | |
| -0.24% | +2.09% | +50.62% | +214.31% | 55.14B | |
| +8.80% | +38.50% | +38.50% | +38.50% | 41.58B | |
| +2.31% | +8.85% | -50.66% | -57.98% | 37.99B | |
| +1.22% | +0.46% | +58.02% | -29.85% | 29.47B | |
| -0.95% | -2.23% | +125.45% | -49.01% | 23.97B | |
| +3.89% | +9.57% | +57.17% | +73.67% | 21.67B | |
| -2.37% | -0.07% | -7.65% | +145.48% | 17.28B | |
| -1.74% | +5.04% | +66.81% | +122.31% | 16.7B | |
| Average | +1.19% | +2.22% | +40.00% | +57.63% | 31.11B | |
| Weighted average by Cap. | +1.68% | +2.02% | +34.71% | +46.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 636M 560M 517M 483M 905M 59.97B 922M 6.21B 2.4B 29.58B 2.39B 2.34B 103B | 718M 632M 583M 545M 1.02B 67.67B 1.04B 7.01B 2.71B 33.38B 2.7B 2.64B 116B |
| Net income | 231M 203M 188M 176M 329M 21.79B 335M 2.26B 874M 10.75B 868M 849M 37.39B | 316M 278M 257M 240M 450M 29.81B 458M 3.09B 1.2B 14.7B 1.19B 1.16B 51.16B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/06/26 | $31.42 | +0.06% | 1,180,755 |
| 23/06/26 | $31.40 | +0.06% | 948,604 |
| 22/06/26 | $31.38 | 0.00% | 2,097,512 |
| 18/06/26 | $31.38 | -0.06% | 3,354,254 |
| 17/06/26 | $31.40 | +0.16% | 2,868,492 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions
